27 Mar 2020 --- Africa could become the next major growth market for BioGaia’s probiotics, according to the Swedish biotech firm’s 2019 annual review. The company notes that the US was its largest market for the first time last year, while China saw the biggest sales increase. However, BioGaia, which highlights Paediatrics as its largest segment, reports that a change in agreement with Nestlé led to a major drop in its royalty revenues, with EMEA sales falling 9 percent.
